Manufacturing and Production

Showing 15 posts of 5867 posts found.

Xoma opts out of in-house manufacturing

January 16, 2012 Manufacturing and Production Xoma, manufacturing

US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …

Europe wants regulatory reform over PIP implant scandal

January 16, 2012 Manufacturing and Production, Sales and Marketing EC, MHRA, PIP implants

The European Commission is seeking regulatory reform for class III medical devices after problems with French-made breast implants. The French …

Covidien appoints Mark Trudeau President of pharmaceuticals segment

January 16, 2012 Business Services, Manufacturing and Production, Sales and Marketing Covidien

Covidien has announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the company. …

Novartis to cut 2,000 US jobs

January 13, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …

Glide Pharma appoints Dr Ian Smith as its new chief executive

January 12, 2012 Business Services, Manufacturing and Production, Sales and Marketing

Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Richard Barker joins Aegate as a senior advisor

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …

Allergan plans $350m expansion of Irish plant

January 10, 2012 Manufacturing and Production Allergan, Ireland

Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …

USP takes aim at supply chain security for medicines

January 10, 2012 Manufacturing and Production US Pharmacopoeial Convention, USP, supply chains

The US Pharmacopoeial Convention (USP) has published the draft of a new general chapter designed to lay out best practices …

Scientists make drug delivery smooth as silk

January 10, 2012 Manufacturing and Production Silk, manufacturing, microneedles

Researchers in the US have developed a new drug delivery system based on silk, which could allow drugs and vaccines …
Novartis building

Novartis recalls products as GMP issues close OTC facility

January 9, 2012 Manufacturing and Production FDA, Novartis, OTC

Novartis has revealed that it is temporarily shutting down a manufacturing facility in Nebraska, US, and recalling four products as …

Celgene appoints Dr David Gillen as its UK and Ireland medical director

January 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene

Celgene has appointed former Pfizer man Dr David Gillen as its new UK and Ireland medical director. Gillen brings much …

Hospira faces lawsuits from disgruntled investors

January 9, 2012 Manufacturing and Production Hospira, generics, manufacturing

Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …
Merkel and Sarkozy

2011 Year In Review

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review

A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …

New requirements for the technical validations of Marketing Authorisation Applications

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …
The Gateway to Local Adoption Series

Latest content